Evidence map›Paper›PMID 40564110›Full record

ArticleBiomedicines2025

Immunological Markers of Cardiovascular Pathology in Older Patients.

Akbota Bugibayeva, Almagul Kurmanova, Kuat Abzaliyev, Symbat Abzaliyeva, Gaukhar Kurmanova, Diana Sundetova, Merei Abdykassymova, Raushan Bitemirova, Ulzas Sagalbayeva, Karashash Absatarova and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akbota BugibayevaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0003-1417-2711
Almagul KurmanovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-1859-3903
Kuat AbzaliyevFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0003-2452-854X
Symbat AbzaliyevaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-2618-1298
Gaukhar KurmanovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-5768-0209
Diana SundetovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0003-2343-869X
Merei AbdykassymovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-5365-5508
Raushan BitemirovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-5228-6018
Ulzas SagalbayevaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0001-7903-9116
Karashash AbsatarovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Madina SuleimenovaFaculty of Information Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0009-0003-8553-5353

Funding

Committee of Science and Higher Education of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP19677754
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular diseasescytokinescytotoxic lymphocytesimmunophenotypingimmunosenescencemonocytes

Identifiers

PMID40564110
PMCPMC12189633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.